|
DLGAP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63824509513688E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06039999999241E-05 |
| Normal-vs-Stage2 |
1.144650E-01 |
| Normal-vs-Stage3 |
1.230190E-04 |
| Normal-vs-Stage4 |
6.159400E-03 |
| Stage1-vs-Stage2 |
5.198800E-01 |
| Stage1-vs-Stage3 |
3.076600E-03 |
| Stage1-vs-Stage4 |
1.259300E-03 |
| Stage2-vs-Stage3 |
1.047750E-01 |
| Stage2-vs-Stage4 |
2.010600E-01 |
| Stage3-vs-Stage4 |
9.443000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.46890285993118E-11 |
| Normal-vs-AfricanAmerican |
1.977350E-03 |
| Normal-vs-Asian |
8.139600E-02 |
| Caucasian-vs-AfricanAmerican |
9.488000E-01 |
| Caucasian-vs-Asian |
7.019700E-02 |
| AfricanAmerican-vs-Asian |
1.321970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.47468712188947E-13 |
| Normal-vs-Female |
2.45849999999104E-05 |
| Male-vs-Female |
2.304300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.832600E-04 |
| Normal-vs-Extreme_Weight |
3.89540000256261E-09 |
| Normal-vs-Obese |
3.67009999999723E-05 |
| Normal-vs-Extreme_Obese |
9.909800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.519560E-01 |
| Normal_Weight-vs-Obese |
5.538800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.051900E-02 |
| Extreme_Weight-vs-Obese |
2.561900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.052800E-01 |
| Obese-vs-Extreme_Obese |
2.341900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.219940E-02 |
| Normal-vs-Age(41-60Yrs) |
8.71450023254283E-10 |
| Normal-vs-Age(61-80Yrs) |
1.84402999999778E-05 |
| Normal-vs-Age(81-100Yrs) |
1.178050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.017700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.084300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.180100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.532590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.551600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.741000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.30526750203353E-14 |
| Normal-VS-Type2 PRCC |
3.24699999998401E-06 |
| Normal-VS-KIRP CIMP |
3.264700E-03 |
| Normal-VS-Unclassified PRCC |
1.561160E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.896500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.624500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.991900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.258300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.324600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.817100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.986200E-04 |
| Normal-vs-N1 |
4.67090000000336E-06 |
| Normal-vs-N2 |
1.116810E-01 |
| N0-vs-N1 |
9.574300E-04 |
| N0-vs-N2 |
5.435800E-01 |
| N1-vs-N2 |
2.503400E-01 |
|
|
